Medigene AG buy MoneyMoney
Start price
10.01.16
/
50%
€8.96
Target price
28.12.16
€13.00
Performance (%)
33.93%
End price
28.12.16
€12.00
Summary
This prediction ended on 28.12.16 with a price of €12.00. The BUY prediction by MoneyMoney for Medigene AG saw massive gains of 33.93%. MoneyMoney has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medigene AG | 2.303% | 2.303% | -8.529% | -62.165% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
According to MoneyMoney what are the pros and cons of Medigene AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Significant cyclical dependencies
Comments by MoneyMoney for this prediction
In the thread Medigene AG diskutieren
Medigene NA
Bei der Aktie von Medigene war es in 2015 ein Auf und Ab.
Aufgrund der Fokussierung auf das Kerngeschäft glaube ich an wieder steigende Kurse , zumindest auf mittelfristiger Sicht .
(Laufzeit überschritten)
Stopped prediction by MoneyMoney for Medigene AG
Medigene AG
Start price
Target price
Perf. (%)
€3.79
22.02.22
22.02.22
€4.00
22.02.23
22.02.23
-45.05%
23.02.23
23.02.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€14.12
09.04.18
09.04.18
€20.00
18.11.19
18.11.19
-58.75%
18.11.19
18.11.19
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€13.67
05.09.17
05.09.17
€17.00
24.01.18
24.01.18
25.09%
24.01.18
24.01.18
Could be worthwhile Investment >10% per year
Significant cyclical dependencies